enCore Energy Corp. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EU
NEW YORK, NY / ACCESS Newswire / April 6, 2025 / If you suffered a loss on your enCore Energy Corp. ( NASDAQ:EU ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E.
Pay Close Attention to This Crucial Revenue Source for Artificial Intelligence ( AI ) Giant IBM
The mostly forgotten former technology titan may quietly be sitting on the next big thing in AI's ongoing evolution.
Mastercard Is Taking On the World and Winning
The Mastercard ( NYSE: MA ) logo is pretty ubiquitous in the United States. It adorns credit cards, debit cards, store windows, websites, and credit card processing machines. That speaks to the size and success of the company's business.
Is This Artificial Intelligence IPO a Buy?
Although recent stock market volatility has pushed down prices for many stocks, the artificial intelligence ( AI ) sector remains a compelling investment, with the tremendous transformative potential it brings to many industries.As Lisa Su, CEO of semiconductor giant Advanced Micro Devices, ...
Rivian Deliveries Tank, but It's Not Time to Panic
Investors knew that 2025 might be a slow one for Rivian Automotive ( NASDAQ: RIVN ) . The young electric vehicle ( EV ) maker doesn't have any obvious catalysts to boost demand or deliveries throughout the year, and its highly anticipated R2 model doesn't launch until 2026.
Mark Cuban Says Cost Plus Drugs Faces Price Hike Threat-'Tariffs Would Force Us To Pass Costs Directly To Consumers'
Imagine finally finding a pharmacy that doesn't drain your bank account-only for prices to suddenly spike. That's the situation Mark Cuban's Cost Plus Drugs might face, thanks to new tariff policies that could force the low-cost drug company to raise prices.
Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA - Neumora Therapeutics ( NASDAQ:NMRA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Neumora To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi Reminds Mullen Automotive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MULN - Mullen Automotive ( NASDAQ:MULN )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Mullen To Contact Him Directly To Discuss Their Options
You Don't Need Talent to Succeed: Lessons From Warren Buffett's Lifetime of Investing
Warren Buffett is, perhaps, one of the most famous investors of all time. Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) , his investment vehicle, has trounced the S&P 500 over the long term. Yet, Buffett has said he has no special talent.
Faruqi & Faruqi Reminds Monolithic Power Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - MPWR - Monolithic Power Systems ( NASDAQ:MPWR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Monolithic Power Systems To Contact Him Directly To Discuss Their Options